|4Apr 4, 7:07 PM ET

Brown Douglas Matthew 4

4 · NEOGENOMICS INC · Filed Apr 4, 2022

Insider Transaction Report

Form 4
Period: 2022-04-01
Brown Douglas Matthew
Chief Strategy Officer
Transactions
  • Award

    Common Stock

    2022-04-01+82,305158,684 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $28.33Exp: 2027-03-02Common Stock (45,017 underlying)
    45,017
  • Stock Option (Right to Buy)

    Exercise: $21.41Exp: 2029-03-01Common Stock (85,519 underlying)
    85,519
  • Stock Option (Right to Buy)

    Exercise: $53.17Exp: 2028-03-02Common Stock (26,378 underlying)
    26,378
Footnotes (4)
  • [F1]On April 1, 2022, Mr. Brown was granted 82,305 restricted stock awards. These awards vest on the first anniversary date of the grant date.
  • [F2]On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  • [F3]On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  • [F4]On March 1, 2022, Mr. Brown was granted 85,519 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

1 file
  • 4
    wf-form4_164911361608506.xmlPrimary

    FORM 4